|Printable version||E-mail this to a friend|
Cancer Research UK - Cancer survival improves in England
Cancer survival has steadily climbed over the last seven years, according to official figures(link is external) from the Office for National Statistics (ONS).
Researchers followed patients who were diagnosed with one of the 24 commonest types of cancer between 2010 and 2014.
Overall, both 1 year and 5 year survival has increased since 2009.
More than 8 out of 10 people affected by cancers of the breast (in women), prostate, testis and thyroid gland, and for Hodgkin lymphoma and melanoma of the skin, survive their disease for at least five years, as medical advances, public awareness campaigns and other public health measures have improved the way doctors diagnose and treat these diseases.
As more people are surviving cancer, there is a need to develop kinder treatments, to help make sure patients have the best quality of life during and after their cancer journey.
For the first time, the figures also included predicted 10 year survival numbers. More than 8 in 10 people diagnosed with melanoma skin cancer or breast cancer are predicted to survive at least ten years or more.
But the picture is very different for other cancer types. Fewer than 15% of people with lung, pancreatic, oesophageal cancers or brain tumours are expected to be alive ten years after their diagnosis.
For cancers that occur in both sexes, survival tends to be higher in women. But there are exceptions - bladder cancer, for example, has a higher five-year survival (57%) in men compared to women (48%).
Commenting on the new figures, Dr Rebecca Smittenaar, Cancer Research UK’s statistics manager, said: “Cancer survival is improving and has doubled over the last 40 years. For a number of cancers, including breast and skin cancer, more than eight out of 10 people will survive their disease. Research has led to better treatments, new drugs, more accurate tests, earlier diagnosis and screening programmes – giving patients a better chance of survival.
But while more people are beating cancer, experts claim more still needs to be done to challenge its position as the number one cause of death in England and Wales.
Dr Smittenaar added, “Far too many people still die from the disease. Improving survival is a priority in England’s cancer strategy. We want to see the strategy put into action across the country, so that no matter where you live you have the best possible chance of surviving cancer.
“Survival remains low for some cancers, including lung, pancreatic, oesophageal cancer and brain tumours, partly because they tend to be diagnosed at a later stage when they're much harder to treat. To turn this around Cancer Research UK has increased investment in these cancers and is carrying out vital research to help save more lives.”
Office for National Statistics bulletin(link is external)
Latest News from
Cancer Research UK - Global smoking rates have fallen since introduction of international tobacco control strategy23/03/2017 14:35:00
Smoking rates have fallen globally since the World Health Organisation (WHO) introduced a treaty aimed at reducing tobacco demand, according to a new study.
Age UK - Over half of lonely older people have never talked about it21/03/2017 13:35:00
Worrying figures revealed in Gransnet survey as the Jo Cox Commission on Loneliness launches its spotlight on older people month.
Cancer Research UK - Radiotherapy risks are much higher for smokers21/03/2017 12:35:00
Smokers treated for breast cancer have much higher risks than non-smokers of developing lung cancer or heart attack as a result of radiotherapy – according to a new study funded by Cancer Research UK and published yesterday in the Journal of Clinical Oncology
Age UK - Hike in calls to advice line over winter as more people seek help21/03/2017 08:35:00
Age UK saw a 12 per cent increase in calls to its national advice line from older people seeking help this winter compared to the same period last year, with enquiries about residential care the most frequent reason for getting in touch.